BMI 30 (or 27 with comorbidity)
In patients with type 2 diabetes and rheumatoid arthritis, retrospective analyses suggest that GLP-1 receptor agonists may provide glycemic and weight benefits comparable to those seen in the general diabetes population, without apparent increases in rheumatoid arthritis flares or complications, though these observations are based on small samples
Yes, both will likely be more expensive
When used in combination, these peptides may enhance growth hormone signaling through complementary mechanisms, making them of interest for research into applications such as age-related muscle loss, metabolic disorders, and other conditions associated with altered growth hormone regulation
Through peptide therapy, we rebuild your skin from the inside out for natural yet noticeable improvements in your skins texture, tone, and overall radiance
So, the modern medical solution to this mismatch between the foods we were built to eat, that naturally activate satiety circuits, and the processed junk were now being sold is to physically, surgically change our anatomy to force it to the end of our gut, or inject GLP-1 mimicking drugs, so we get GLP-1 activation regardless of what we eat